| Literature DB >> 36135215 |
Abstract
Sudden Infant Death Syndrome (SIDS) occurs unexpectedly in an otherwise healthy infant with no identifiable cause of death following a thorough investigation. A general hypervolemic state has been identified in SIDS, and fluid in the lungs suggests the involvement of pulmonary edema and hypoxia as the cause of death. The present perspective paper reviews pathophysiological, epidemiological, and dietary evidence in SIDS. A grounded theory is presented that proposes an association of SIDS with sodium toxicity from excessive sodium chloride intake, mediated by noncardiogenic pulmonary edema, hypoxia, and alveolar damage. The peak of SIDS cases occurs in infants 2-4 months of age, who are less efficient in excreting excessive dietary sodium load. Evidence implicating sodium toxicity in SIDS includes increased levels of sodium associated with fever and with inflammatory/immune responses in the lungs. Conditions in near-miss SIDS cases are linked to dysregulated sodium, and increased sodium dietary intake suggests that sodium toxicity from a high-salt diet potentially mediates the association of seasonality and socioeconomic status with SIDS incidence. In addition, exposure to sodium toxicity meets three main criteria of the triple risk model of SIDS. The proposed pathophysiological effects of pulmonary edema related to sodium toxicity in SIDS merit further investigations.Entities:
Keywords: SIDS; alveolar epithelium; fever; hypervolemia; hypoxia; microvascular endothelium; pulmonary edema; sodium chloride; sudden infant death syndrome
Year: 2022 PMID: 36135215 PMCID: PMC9497894 DOI: 10.3390/diseases10030059
Source DB: PubMed Journal: Diseases ISSN: 2079-9721
Figure 1In noncardiogenic pulmonary edema, fluid flows into the interstitium through the disrupted microvascular endothelial barrier, then subsequently flows into the alveolus through the disrupted epithelial barrier.
Figure 2The association of sodium toxicity with sudden infant death syndrome (dotted arrow) is mediated (straight arrows) by disruptions of the microvascular endothelial and alveolar epithelial barriers in the lungs, leading to pulmonary edema and hypoxia (straight arrows).